VEGF-A164/165 and PlGF: Roles in angiogenesis and arteriogenesis

Trends in Cardiovascular Medicine

Volumn 13, Issue 5, 2003, Pages 169-175

  Nagy, Janice A ^a,b   Dvorak, Ann M ^a,b   Dvorak, Harold F ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CYTOKINE; PLACENTAL GROWTH FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ANGIOGENESIS; ARTERIOVENOUS MALFORMATION; ARTERY DIAMETER; ATHEROSCLEROSIS; BASEMENT MEMBRANE; BLOOD VESSEL; BLOOD VESSEL PERMEABILITY; BLOOD VESSEL REACTIVITY; CAPILLARY; CYTOKINE PRODUCTION; DRUG EFFECT; EDEMA; ENDOTHELIUM CELL; EXPRESSION VECTOR; FIBROBLAST; FIBROSIS; GLOMERULOID BODY; GLOMERULUS; ISCHEMIA; ISCHEMIC HEART DISEASE; LYMPH VESSEL; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; VASCULAR ENDOTHELIUM; VASCULARIZATION; VEIN DIAMETER; WOUND HEALING;

EID: 0038692867     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(03)00056-2     Document Type: Review

References (39)

1. Adini A., Kornaga T., Firoozbakht F., Benjamin L.E. Placental growth factor is a survival factor for tumor endothelial cells and macrophages. Cancer Res. 62:2002;2749-2752.
2. Benjamin L.E., Golijanin D., Itin A.et al. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest. 103:1999;159-165.
3. Brown L.F., Detmar M., Claffey K.et al. Vascular permeability factor/vascular endothelial growth factor. a multifunctional angiogenic cytokine EXS. 79:1997;233-269.
4. Brown L.F., Yeo K.T., Berse B.et al. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med. 176:1992;1375-1379.
5. Carmeliet P., Moons L., Luttun A.et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med. 7:2001;575-583.
6. De Falco S., Gigante B., Persico M.G. Structure and function of placental growth factor. Trends Cardiovasc Med. 12:2002;241-246.
7. Dvorak H.F., Nagy J.A., Feng D.et al. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol. 237:1999;97-132.
8. Dvorak H.F. Vascular permeability factor/vascular endothelial growth factor. a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy J Clin Oncol. 20:2002;4368-4380.
9. Epstein S.E., Fuchs S., Zhou Y.F.et al. Therapeutic interventions for enhancing collateral development by administration of growth factors. basic principles, early results and potential hazards Cardiovasc Res. 49:2001;532-542. a.
10. Epstein S.E., Kornowski R., Fuchs S., Dvorak H.F. Angiogenesis therapy. amidst the hype, the neglected potential for serious side effects Circulation. 104:2001;115-119. b.
11. Feng D., Nagy J.A., Dvorak A.M., Dvorak H.F. Different pathways of macromolecule extravasation from hyperpermeable tumor vessels. Microvasc Res. 59:2000;24-37.
12. Ferrara N., Keyt B. Vascular endothelial growth factor. basic biology and clinical implications EXS. 79:1997;209-232.
13. Hammond H.K., McKirnan M.D. Angiogenic gene therapy for heart disease. a review of animal studies and clinical trials Cardiovasc Res. 49:2001;561-567.
14. Hasegawa T., Kimura A., Miyataka M.et al. Basic fibroblast growth factor increases regional myocardial blood flow and salvages myocardium in the infarct border zone in a rabbit model of acute myocardial infarction. Angiology. 50:1999;487-495.
15. Hattori K., Heissig B., Wu Y.et al. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nat Med. 8:2002;841-849.
16. Henry T.D., Abraham J.A. Review of preclinical and clinical results with vascular endothelial growth factors for therapeutic angiogenesis. Curr Int Cardiol Rep. 2:2000;228-241.
17. Isner J.M. Myocardial gene therapy. Nature. 415:2002;234-239.
18. Lederman R.J., Mendelsohn F.O., Anderson R.D.et al. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study). a randomised trial Lancet. 359:2002;2053-2058.
19. Li J., Brown L.F., Hibberd M.G.et al. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol. 270:1996;H1803-H1811.
20. Lopez J.J., Edelman E.R., Stamler A.et al. Angiogenic potential of perivascularly delivered aFGF in a porcine model of chronic myocardial ischemia. Am J Physiol. 274:1998;H930-H936. a.
21. Lopez J.J., Laham R.J., Stamler A.et al. VEGF administration in chronic myocardial ischemia in pigs. Cardiovasc Res. 40:1998;272-281. b.
22. Losordo D.W., Vale P.R., Isner J.M. Gene therapy for myocardial angiogenesis. Am Heart J. 138:1999;132-141.
23. Luttun A., Tjwa M., Moons L.et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med. 8:2002;831-840.
24. McKee P: 1996. Pathology of the skin with clinical correlations. London, Mosby International, pp. 16.57-16.66.
25. Miao H.Q., Lee P., Lin H.et al. Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression. FASEB J. 14:2000;2532-2539.
26. Nagy J.A., Vasile E., Feng D.et al. Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med. 196:2002;1497-1506.
27. Nagy JA, Vasile E, Feng D, et al.: 2003. VEGF-A induces angiogenesis, arteriogenesis, lymphangiogenesis and vascular malformations. In Symposium 67: The Cardiovascular System. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, in press.
28. Odorisio T., Schietroma C., Zaccaria M.L.et al. Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability. J Cell Sci. 115:2002;2559-2567.
29. Oura H., Bertoncini J., Velasco P.et al. A critical role of placental growth factor in the induction of inflammation and edema formation. Blood. 101:2003;560-567.
30. Pettersson A., Nagy J.A., Brown L.F.et al. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab Invest. 80:2000;99-115.
31. Pipp F., Heil M., Issbrucker K.et al. VEGFR-1-selective VEGF homologue PlGF is arteriogenic. evidence for a monocyte-mediated mechanism Circ Res. 92:2003;378-385.
32. Rafii S., Meeus S., Dias S.et al. Contribution of marrow-derived progenitors to vascular and cardiac regeneration. Semin Cell Dev Biol. 13:2002;61-67.
33. Schaper W., Buschmann I. Arteriogenesis, the good and bad of it. Cardiovasc Res. 43:1999;835-837.
34. Scholz D., Cai W.J., Schaper W. Arteriogenesis, a new concept of vascular adaptation in occlusive disease. Angiogenesis. 4:2001;247-257.
35. Scholz D., Elsaesser H., Sauer A.et al. Bone marrow transplantation abolishes inhibition of arteriogenesis in placenta growth factor (PlGF) -/- mice. J Mol Cell Cardiol. 35:2003;177-184.
36. Sundberg C., Nagy J.A., Brown L.F.et al. Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery. Am J Pathol. 158:2001;1145-1160.
37. Swayne G.T., Smaje L.H., Bergel D.H. Distensibility of single capillaries and venules in the rat and frog mesentery. Int J Microcirculation. 8:1989;25-42.
38. van Royen N., Piek J.J., Buschmann I.et al. Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease. Cardiovasc Res. 49:2001;543-553.
39. Watanabe Y., Lee S.W., Detmar M.et al. Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal microvascular endothelial cells. Oncogene. 14:1997;2025-2032.